You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types

 

Online download statistics by month:

Online download statistics by month: February 2024 to September 2025

AbstractFullPdf
Feb 202411871191386
Mar 202415911612388
Apr 2024956975219
May 2024609620147
Jun 2024790723156
Jul 2024282287115
Aug 202447347970
Sep 202421121186
Oct 202420020395
Nov 202417318186
Dec 202416416865
Jan 2025243244124
Feb 2025478486110
Mar 2025185189141
Apr 2025245245108
May 2025173174102
Jun 20259595453
Jul 2025110
Sep 2025110
Total805780852851